141 related articles for article (PubMed ID: 12352662)
1. Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.
Lasak JM; Welling DB; Akhmametyeva EM; Salloum M; Chang LS
Laryngoscope; 2002 Sep; 112(9):1555-61. PubMed ID: 12352662
[TBL] [Abstract][Full Text] [Related]
2. cDNA microarray analysis of vestibular schwannomas.
Welling DB; Lasak JM; Akhmametyeva E; Ghaheri B; Chang LS
Otol Neurotol; 2002 Sep; 23(5):736-48. PubMed ID: 12218628
[TBL] [Abstract][Full Text] [Related]
3. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
Halum SL; Erbe CB; Friedland DR; Wackym PA
Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
[TBL] [Abstract][Full Text] [Related]
4. Deregulated genes in sporadic vestibular schwannomas.
Cayé-Thomasen P; Borup R; Stangerup SE; Thomsen J; Nielsen FC
Otol Neurotol; 2010 Feb; 31(2):256-66. PubMed ID: 19816230
[TBL] [Abstract][Full Text] [Related]
5. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase/AKT pathway activation in human vestibular schwannoma.
Jacob A; Lee TX; Neff BA; Miller S; Welling B; Chang LS
Otol Neurotol; 2008 Jan; 29(1):58-68. PubMed ID: 18199958
[TBL] [Abstract][Full Text] [Related]
7. Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas.
Aarhus M; Bruland O; Sætran HA; Mork SJ; Lund-Johansen M; Knappskog PM
Neurosurgery; 2010 Oct; 67(4):998-1019; discussion 1019. PubMed ID: 20881564
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D(1) and D(3) expression in vestibular schwannomas.
Neff BA; Oberstien E; Lorenz M; Chaudhury AR; Welling DB; Chang LS
Laryngoscope; 2006 Mar; 116(3):423-6. PubMed ID: 16540902
[TBL] [Abstract][Full Text] [Related]
9. [Expression of cell cycle control genes in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression between human schwannoma and control Schwann cells.
Hanemann CO; Bartelt-Kirbach B; Diebold R; Kämpchen K; Langmesser S; Utermark T
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):605-14. PubMed ID: 17083475
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 expression and histopathologic features in vestibular schwannomas.
Lassaletta L; Patrón M; Del Río L; Alfonso C; Roda JM; Rey JA; Gavilan J
Otol Neurotol; 2007 Oct; 28(7):939-41. PubMed ID: 17704717
[TBL] [Abstract][Full Text] [Related]
12. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
Glassford J; Rabin N; Lam EW; Yong KL
Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
[TBL] [Abstract][Full Text] [Related]
14. [Neurotrophic factor expression in vestibular schwannoma. An overview].
Diensthuber M; Lenarz T; Stöver T
Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
[TBL] [Abstract][Full Text] [Related]
15. The molecular biology and novel treatments of vestibular schwannomas.
Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I
J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959
[TBL] [Abstract][Full Text] [Related]
16. Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.
Nonomura Y; Nagasaka K; Hagiyama H; Sekine C; Nanki T; Tamamori-Adachi M; Miyasaka N; Kohsaka H
Arthritis Rheum; 2006 Jul; 54(7):2074-83. PubMed ID: 16802342
[TBL] [Abstract][Full Text] [Related]
17. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
18. Abnormal cell cycle regulation in primary human uveal melanoma cultures.
Pardo M; Piñeiro A; de la Fuente M; García A; Prabhakar S; Zitzmann N; Dwek RA; Sánchez-Salorio M; Domínguez F; Capeans C
J Cell Biochem; 2004 Nov; 93(4):708-20. PubMed ID: 15660415
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
